Latest technology reporting
Evidence-led coverage of biotechnology, AI infrastructure, energy, robotics, devices and brain–computer interfaces.
-
Optical AI Data Centre Networks: Why Lasers Are Replacing Copper
Explore how optical AI data centre networks move data, why co-packaged optics matters, and the power, reliability and cost trade-offs that remain.
-
AI Data Centre Liquid Cooling: Why Future Servers Need Plumbing
AI data centre liquid cooling moves heat from dense server racks. Learn how cold plates, warm water and facility design affect power and water use.
-
CRISPR Gene Therapy Approved for Children as Young as Two
Casgevy is approved from age two for sickle-cell disease with recurrent vaso-occlusive crises or transfusion-dependent beta thalassaemia. Learn the risks.
-
Pancreatic Cancer Prevention Vaccine Trains Immunity Before Disease
A small Phase 1 KRAS vaccine trial produced immune responses in people at inherited pancreatic cancer risk. It has not established cancer prevention.
-
Tiny CRISPR Could Unlock Gene Editing Inside the Body
A compact CRISPR enzyme could fit a complete editor into one AAV vector. Explore the preclinical research and unresolved delivery and safety questions.
-
Cholesterol Base Editing: Can One Infusion Replace Years of Treatment?
VERVE-102 lowered LDL in a small Phase 1b cholesterol base-editing trial. Explore the PCSK9 mechanism and why long-term safety and benefit remain unproven.
-
In Vivo CRISPR Gene Editing Passes Its First Phase 3 Test
Intellia reports fewer hereditary angioedema attacks in a Phase 3 lonvo-z trial. In vivo CRISPR still needs regulatory review and longer safety follow-up.
-
Partial Epigenetic Reprogramming Enters Human Trials
Partial epigenetic reprogramming has entered a Phase 1 eye-disease trial. Here is what ER-100 is testing, how OSK works and what remains unproven.
-
Off-the-Shelf CAR-T Reaches a Pivotal Leukaemia Trial
Off-the-shelf CAR-T candidate lasme-cel has entered a pivotal B-ALL trial after encouraging early responses. Here is how it works and why the evidence remains preliminary.
-
AI Data Centre Energy: The 1-Gigawatt Savannah River Plan
A proposed 1-gigawatt AI data centre at Savannah River would use about 2 gigawatts of on-site energy, starting with gas and moving toward nuclear.
-
Australia Plans National AI Data-Centre Standards as Power Demand Surges
Australia’s proposed AI data centre standards turn the country’s artificial-intelligence build-out from a technology story into an infrastructure test: how quickly can electricity, water and network capacity be added without shifting the bill to households and other businesses? That challenge came into sharper focus in August 2026. The Australian Energy Market Operator (AEMO) forecast a…
-
Personalised mRNA Cancer Vaccine Meets Its Phase 3 Goals in Melanoma
Moderna and Merck say a cancer vaccine built from each patient’s tumour has met the key goals of a large Phase 3 melanoma trial—a major validation of personalised mRNA biotechnology, although the full results are still pending.